Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 00:59 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Phenylketonuria, Oxidative Stress, and BH4
NCT01395394 · Emory University · PHASE2 · terminated · last registry update 2014-08-28 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “Difficulty with recruitment and agreed with Sponsor to report completed data as case reports” | – | Registry record, Emory University |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against PAH within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2015-07-07Results posted on the registry: The University of Texas Health Science Center, Houston, Sapropterin (NCT01541397)
- 2015-07-07Also stopped (terminated): The University of Texas Health Science Center, Houston, Sapropterin (NCT01541397)
- 2015-06-01Results posted on the registry: Emory University, Tetrahydrobiopterin + Placebo (NCT01356966)
- 2015-05-12Results posted on the registry: Children's Hospital of Philadelphia, Sapropterin (NCT00986973)
- 2014-12-17Also stopped (withdrawn): Children's National Research Institute, sapropterin dihydrochloride + sapropterin dihydrochloride (NCT01412437)
- 2014-07-28Results posted on the registry: Merck KGaA, Darmstadt, Germany, Kuvan® (NCT01732471)
- 2014-04-08Results posted on the registry: University of Utah, Sapropterin (NCT01425528)
- 2014-02-28Results posted on the registry: The Children's Health Council, sapropterin + Placebo (NCT00850070)
- 2014-02-24Results posted on the registry: The University of Texas Health Science Center, Houston, sapropterin dihydrochloride (NCT01141595)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision